Achieving Blood Pressure Control Through Enhanced Discharge (AchieveBP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02069015|
Recruitment Status : Completed
First Posted : February 21, 2014
Last Update Posted : November 15, 2016
|Condition or disease||Intervention/treatment|
|Hypertension||Behavioral: Patient education|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Achieving Blood Pressure Control Through Enhanced Discharge|
|Study Start Date :||October 2013|
|Primary Completion Date :||June 2015|
|Study Completion Date :||June 2016|
Experimental: Enhanced discharge
Patient education about hypertension delivered through a touch-screen kiosk at 4 time points in addition to standard discharge.
Behavioral: Patient education
Patient education on hypertension delivered through a touchscreen kiosk.
No Intervention: Standard discharge
Standard discharge is patient instruction, instructions for follow-up to primary care and medication/prescription
- Blood pressure control [ Time Frame: Baseline to ninety days ]Blood pressure readings of 140/90 for non-diabetic participants, and 130/80 for diabetic persons. Additionally, actual systolic and diastolic readings will be used as a continuous measure to determine if there is a significant change.
- Patient activation measure (PAM) [ Time Frame: Baseline to 90 days ]Measure of how actively involved patient is in their medical care.
- Emergency department visitation rate [ Time Frame: Baseline to 180 days ]Emergency department visits related to hypertension
- Patient centered cost effectiveness [ Time Frame: 180 days ]Patient willingness to pay
- Patient centered cost effectiveness [ Time Frame: 180 days ]Patient willingness to accept
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02069015
|United States, Michigan|
|Detroit Receiving Hospital Emergency Department|
|Detroit, Michigan, United States, 48201|
|Principal Investigator:||Julie A Gleason-Comstock, PhD||Wayne State University|
|Principal Investigator:||Phillip D Levy, MD||Wayne State University|